Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT06117982
PHASE2

The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency

Sponsor: Trio Fertility

View on ClinicalTrials.gov

Summary

The goal of this pilot study is to improve ovarian reserve markers in patients with premature ovarian insufficiency. The main question it aims to answer is: \- Will treatment with G-CSF allow improvement in markers of ovarian reserve?

Official title: Does Subcutaneous Granulocyte Colony Stimulating Factor (G-CSF) Improve Ovarian Reserve in Women With Premature Ovarian Insufficiency?

Key Details

Gender

FEMALE

Age Range

25 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

11

Start Date

2023-10-13

Completion Date

2025-05-01

Last Updated

2026-08-20

Healthy Volunteers

Yes

Interventions

DRUG

Neupogen

Subcutaneous injection of 0.5 ml of Neupogen at a concentration of 300 micrograms/day for 4 consecutive days

Locations (1)

Trio Fertility

Toronto, Ontario, Canada